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Abstract: Cryptosporidiosis has been proposed to be one of the major causes of diarrhoeal disease in
humans worldwide that possesses zoonotic concern. Thereby, this study investigated the potential
effects of s-Methylcysteine (SMC) on the parasite in vivo followed by the measurement of cytokines,
oxidative stress parameters, and an investigation of the major histopathological changes. Sixty male
Swiss albino mice weighing 20–25 g were allocated equally into five groups and orally administered
saline only (control), SMC only (SMC50) (50 mg/kg b.w.), and 104 Cryptosporidium parvum oocysts
per mouse via an esophageal tube (C + ve untreated). The fourth and fifth groups (C + SMC25,
C + SMC50) administrated 104 C. parvum oocysts combined with SMC25 (low dose) and 50 (high
dose) mg/kg b.w., respectively. At days 7 and 14 post-infection (PI), the feces was collected from
each group in order to count C. parvum oocysts. After two weeks of treatment, the animals were
euthanized and the serum was collected for biochemical analysis. Next, the intestinal, spleen, and
liver sections were dissected for histopathological examination. The results revealed lower oocyst
numbers in the C + SMC25 and C + SMC50 groups compared to the infected untreated group.
Moreover, higher doses of SMC treatment significantly reduced the enteritis induced by C. parvum in a
dose-dependent manner. The hepatic lesions were also mitigated as demonstrated in C + SMC25 and
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C + SMC50 groups unlike the infected group via lowering the serum alanine aminotransferase (ALT),
aspartate aminotransferase (AST), and alkaline phosphatase (ALP) enzymes and increasing albumin
and globulin serum levels. SMC administration also reduced cytokines production (SAP, TNF-α, IL-6,
and IFN-γ) mediated by Cryptosporidium infection in contrast to the infected untreated group. There
were marked lymphoid depletion and amyloidosis observed in the infected untreated group, while
the treated groups showed obvious increase in the lymphoid elements. Moreover, the scoring of
intestinal parasites, hepatic, and splenic lesions in the SMC-treated groups exhibited significantly
lower pathological lesions in different organs in a dose-dependent manner, compared to the infected
untreated group. Our results also revealed a significant change in the malondialdehyde content with
an elevation of glutathione and superoxide dismutase in the intestines collected from C + SMC25
and C + SMC50 mice relative to the untreated group. Taken together, our results indicated that
SMC could be a promising effective compound for treating and declining C. parvum infestation via
restoring structural alterations in different tissues, enhancing antioxidant enzymes, and suppressing
the cytokines liberation.
Keywords: Cryptosporidium parvum; hepatic damage; inflammatory biomarkers; intestinal injury;
s-Methylcysteine
1. Introduction
Enteric infections remain a major significant public health concern in developing and developed
nations [1–3]. Among others, numerous outbreaks of zoonotic cryptosporidiosis have been described as
major protozoan waterborne cause of diarrhoea in humans worldwide [1,4,5]. This waterborne disease
is caused by leading unicellular protozoan of the genus Cryptosporidium [5,6]. Among all identified
species of this protozoan, Cryptosporidium parvum has been considered an important zoonotic species
with a wide epidemiological profile that includes multiple hosts and reservoirs [4,6,7]. Humans might
contract the infection mainly through the fecal–oral route via ingestion and less likely through inhalation
of coughed on fomites [5,8]. The parasite comprises of three developmental stages that include meronts,
gamonts, and oocysts. Taken into account, the later one can survive for a long period outside the host
and resist disinfectants as a result of the strong protective effect of its oocyst wall [6]. The clinical impact
of the disease ranges from mild to severe or long-term non-bloody diarrhea but the infection could
be recurrent in some immunocompetent hosts and become life-threatening in immunocompromised
individuals such as acquired immunodeficiency syndrome (AIDS) patients and those who receive
immunosuppressive drugs [9,10]. Additionally, cryptosporidiosis might result in significant morbidity
and mortality in human, particularly among children living in resource-poor settings in developing
countries [11–15].
The diagnosis of the disease is usually accomplished through examination of stool for the presence
of oocysts, morphometric identification which is often difficult, and via a combination of methods
incorporating data from morphometric, molecular techniques, and host specificity; however, this
later method is usually encountered with many limitations as a result of cost, duration, expertise, or
reliability [16]. One of the main control strategies of the disease is the development of novel drug targets
for combating the diseases [17]. Despite innumerable studies on developing novel drug targets against
the cryptosporidiosis, no effective chemotherapy is available and the treatment mainly relies on using
combined therapy using paramomycin with protease inhibitors or recombinant Interleukin 12 (IL-12)
or Nitazoxanide [6,17–20]. However, this drug seems to be ineffective in human immunocompromised
individuals and the use of paramomycin has been proved to be suppressive in specific cases [18,19].
Clearly, a complete removal of the parasite from the host remains the main challenge in order to control
the disease in the host.
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It is noteworthy to mention that s-Methylcysteine (SMC) is one of the main organosulfur
compounds that widely occur in many edible vegetables such as garlic [21–23]. Interestingly, several
previous reports have documented a wide range of activities of garlic and its components, particularly
SMC, for treatment of various physiological and pathological conditions [24–26]. In this regard, some
previous reports revealed that garlic, SMC, and other organosulfur compounds of raw or extracted garlic
showed anticancer [27], antioxidant [28], anti-inflammatory [29], antidiabetic [30], cardioprotective [24],
neuroprotective [31], hypocholesterolemic [30], antiinfective [32,33], and hepatoprotective effects [34–
36]. To the authors’ knowledge, no former investigations assessed the effect of SMC against C. parvum
either in vitro or in vivo. Hence, the present study was undertaken to assess the effect of SMC against
the parasite in vivo in an endeavour to develop a novel drug against the parasite. The study also
involved the measurement of various oxidative stress parameters and an investigation of the major
histopathological changes following administration of the drug.
2. Materials and Methods
2.1. Ethical Considerations
The ethical approval of the present study was obtained from a guidance of the Research,
Publication, and Ethics Committee of the Faculty of Veterinary Medicine, Kafrelsheikh University,
Egypt, which complies with all relevant Egyptian legislations in publication and research. The ethical
approval number is KFS-2019/1.
2.2. Materials
S-Methylcysteine, as well as other chemicals and reagents were purchased from Sigma-Aldrich
(Cairo, Egypt). All materials were of analytical grade and used as received.
2.3. Parasite Material and Parasite Preparation
Cryptosporidium parvum oocysts were purchased from the Parasitology Department at the Theodor
Bilharz Research Institute and were stored at 4 ◦C in potassium dichromate 2.5% solution (w/v) in
the Department of Pathology, Faculty of Veterinary Medicine, Kafrelsheikh University, following
the protocol described elsewhere [37]. The oocysts of the parasite were washed shortly before use
three times in distilled water for removal of potassium dichromate, then centrifuged at 1500× g for
10 min, and the organisms were counted with a hemocytometer. Later on, the suspension contained
approximately 104 oocysts/mL which is required for the infection of mice and was prepared by dilution
of the organism in the appropriate amount of distilled water [38].
2.4. Animals and Experimental Protocol
As mentioned above, the present work was conducted in compliance with the Egyptian guidelines
for animal care, handle, and protection. Male Swiss albino mice (fa/fa; 20–25 g body weight (b.w.);
n = 60) at the age of 6 weeks were purchased from Animal house (National Research Centre, Giza,
Egypt) and housed in clean well-ventilated cages under standard laboratory conditions (synchronized
to a 12-h light/dark cycle and at a temperature-controlled room of 24–28 ◦C). Animals were fed on a
standard diet (pelleted food and water) and provided water ad libitum. Furthermore, they were used
for the experiments after one week of the acclimatization period.
At the age of 7 weeks, the animals were divided into 5 groups of 12 mice each as follows:
the first group was administered saline (negative control group), the second group (SMC50) was
only administered s-Methylcysteine at a dose of 50 mg/kg b.w., the third group (C + ve, infected
untreated) was control positive and experimentally infected by 104 C. parvum oocysts per mouse
using an esophageal tube. Importantly, the dose of SMC was determined according to a protocol that
is described elsewhere [24]. The infected group and C + SMC groups were given dexamethasone
sodium phosphate at a dose of 125 µg/day for 14 consecutive days prior to oocysts inoculation
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and throughout the experimental protocol for induction of immunosuppression in infected animals
following the protocol described elsewhere [39]. In accordance with the 4th and 5th group (C + SMC25,
C + SMC50), they were given 104 C. parvum oocysts by intragastric inoculation combined with
s-Methylcysteine-treated groups at a dose of 25 (low dose) and 50 (high dose) mg/kg b.w., respectively.
The treatment protocol is summarized in Figure 1.
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Figure 1. Treatment protocol and doses of used s-Methylcysteine (SMC).
Examination of stools of mice was done microscopically using direct wet saline smear and iodine
stained with acid-fast (AF) stain to detect the presence of Cryptosporidium oocysts. After two weeks
of treatment, the animals were euthanized with diethyl ether inhalation and the collection of blood
samples was done without anticoagulants. The obtained serum was stored at −20 ◦C for further
biochemical analysis. Intestinal tissue sections were collected from different animal groups treated to
be used in antioxidant/oxidative stress markers evaluation. Other intestine, spleen, and liver sections
were dissected and sent to the Department of Pathology, Faculty of Veterinary Medicine, Kafrelsheikh
University, Egypt, for further histopathological examination.
2.5. Measurement of Serum Biochemical Parameters
Measurement of aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin,
globulin, and alkaline phosphatase (ALP) were determined using commercially available diagnostic kits
according to the manufacturer’s instructions (LifeSpan Biosciences, Seattle, WA, USA). Serum Amyloid
P concentration was measured by sandwich ELISA using rabbit SAP serum (US Biological, Salem, MA,
USA). Furthermore, the level of Tumor Necrosis factor alpha, Interferon gamma (IFN-γ), and Interleukin
6 (IL-6) were analyzed by the sandwich ELISA kit RayBiotech (Peachtree Corners, GA, USA).
2.6. Histopathological Examination
Samples from intestine, spleen, and liver of different animal groups were trimmed, fixed in neutral
buffered formalin (10%), dehydrated, cleared, and embedded in paraffin wax. The hard paraffin blocks
were sliced into sections of 5 µm in thicknesses for each organ to make a ribbon of tissue that was
then stained with hematoxylin and eosin (H&E) according to the protocol described elsewhere [40].
Biomedicines 2020, 8, 423 5 of 17
The histological examination of stained slides of the different groups was blindly examined using a
light microscope for quantitative assessment of the histopathological changes.
The reported histopathological lesions were scored upon a 5 points scale which scored from 0 to 5.
The intestinal lesions were assessed on the basis of presence enteritis features as crypt degeneration,
necrosis, desquamation, hyperplasia, and inflammation. Moreover, the number of oocysts within the
intestinal mucosa was counted and expressed as the number/mm2. The hepatic lesions were assessed
according to the degree of congestion, degeneration, apoptosis, necrosis, and granuloma formation.
Lesions on spleen were scored according to congestion, lymphoid depletion, and amyloid deposition.
2.7. Evaluation of Oxidative Stress and Antioxidant Markers
Following intestinal tissues homogenization in phosphate buffer saline and centrifugation at
5000 rpm for 30 min, the resulting supernatants were used to measure the concentration of the oxidative
stress marker, malondialdehyde (MDA) and the activity of antioxidant enzyme, superoxide dismutase
(SOD), and glutathione (GSH) as previously described (Biodiagnostics, Giza, Egypt) [41].
2.8. Statistical Analysis
The values were expressed as mean ± SD and the data were statistically analyzed by one-way
ANOVA using the GraphPad PRISM software v.5 (La Jolla, CA, USA). The statistical significance
variance was considered when p < 0.05.
3. Results
3.1. Effects of s-Methylcysteine (SMC) on Shedding of Cryptosporidium Oocysts
Shedding of C. parvum oocysts (Table 1) was observed in control, infected non-treated (C + ve) and
SMC-treated groups (SMC50, C + SMC25, and C + SMC50 groups) at days 7 and 14 post-infection (PI)
(Figure 2). The mean oocyst number shed in stools of both in the C + SMC25 and C + SMC50 groups
was significantly reduced (p < 0.05) at days 7 and 14 PI when compared to the infected non-treated
group. The lowest oocyst number (p < 0.05) was recorded in the C + SMC50 group counterweight
to the infected non-treated and C + SMC25 groups. Feces of control and SMC50 groups were still
negative for C. parvum oocysts.
Table 1. The number of Cryptosporidium parvum oocysts shed in mice feces collected from different
experimental groups at days 7 and 14 post-infection (PI).
Experimental Groups
Days Post Infection
Control SMC50 C + ve C + SMC25 C + SMC50
Day 7 0.00 ± 0.00 d 0.00 ± 0.00 d 41.20 ± 3.11 a 32.60 ± 3.05 b 23.60 ± 2.51 c
Day 14 0.00 ± 0.00 d 0.00 ± 0.00 d 45.40 ± 4.34 a 18.80 ± 2.59 b 12.00 ± 3.54 c
Data were expressed as mean ± S.D. Control group (received saline, orally); SMC50 (treated with s-Methylcysteine,
50 mg/kg, orally); C + ve (infected with 104 C. parvum oocysts); C + SMC25 (infected and treated with s-Methylcysteine,
25 mg/kg, orally); c: C + SMC50 (infected and treated with s-Methylcysteine, 50 mg/kg, orally). Means within the
same row (in each parameter) carrying different superscripts (a, b, c, d) are significantly different (p < 0.05).
3.2. SMC Attenuates Cryptosporidium-Induced Liver Damage
The levels of serum hepatic enzymes (ALT, AST, and ALP), albumin, and globulins were measured
as biomarkers for liver damage at two weeks PI with C. parvum along with the SMC treatment. As shown
in Table 1, Cryptosporidium infection (infected group) exhibited marked liver damage indicated by an
increased serum of ALT, AST, and ALP levels (p < 0.05) compared to the control group. Meanwhile, the
concomitant SMC treatment, especially the higher dose, significantly reduced (p < 0.05) hepatic damage
as demonstrated in the C + SMC25 and C + SMC50 groups unlike the infected untreated group.
Proteinogram assay illuminated the significant lowest level (p < 0.05) of albumin and globulin
in the infected non-treated group relative to the control. C + SMC25- and C + SMC50-treated mice
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revealed a significant increase in serum albumin and globulin (p < 0.05) counterweight to the infected
non-treated group. Moreover, the highest globulin level (p < 0.05) was demonstrated in the C + SMC50
group in contrast to all other groups including control (Table 2).
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multiple necrotic foci within the hepatic tissues associated with marked aggregation of inflammatory 
cells as lymphocytes, macrophages, and esinophils give the picture of a granulomatous reaction. 
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Figure 2. Serum level of amyloid P (A), Tumor Necrosis factor (TNF-α, (B)), Interleukin 6 (IL-6, (C)), and
Interf ron (IFN-γ, (D)) after two weeks of s-Methylcysteine (SMC) treatment in C. parvum-infected
mice. Cont l (received saline, orally); SMC50 (treated with s-Methylcyst ine, 50 mg/kg, orally); C+ ve
(infected with 104 C. parvum oocysts); C + SMC25 (inf cted and tr ated wi h s-Methylcysteine, 25 mg/kg,
orally); C + SMC50 (infected and treated with s-Methylcysteine, 50 mg/kg, orally). Data were expressed
as mean ± S.D. Each bar carrying differen l t rs (a, b, c, d) is significantly different (p < 0 05).
Table 2. Serum liver biomarkers following s-Methylcysteine treatment in C. parvum-infected mice.
Experimental GroupsSerum Biochemical
Parameters C ntrol SMC50 C + ve C + SMC25 C + SMC50
ALT (U/L) 42.72 ± 2.08 d 39.28 ± 3.52 d 109.22 ± 13.56 a 71.18 ± 7.35 b 53.35 ± 6.77 c
AST (U/L) 58.48 ± 8.70 c 54.34 ± 5.46 c 151.68 ± 14.69 a 83.96 ± 8.97 b 58.52 ± 9.53 c
ALP (U/L) 138.60 ± 13.43 cd 130.60 ± 21.14 d 240.20 ± 10.89 a 179.00 ± 8.60 b 80.154 ± 9.36 c
Albumin (g/dL) 4.42 ± 0.32 a 4.64 ± 0.23 a 2.82 ± 0.19 d 3.38 ± 0.33 c 3.98 ± 0.19 b
Globulin (g/dL) 4.88 ± 0.29 bc 5.04 ± 0.21 b 2.94 ± 0.18 d 4.44 ± 0.58 c 5.70 ± 0.36 a
All data were expressed as mean ± S.D. Means within the same row (in each parameter) carrying different
superscripts (a, b, c, d) are significantly different (p < 0.05). Control (received saline, orally); SMC50 (treated with
s-Methylcysteine, 50 mg/kg, orally); C + ve (infected with 104 C. parvum oocysts); C + SMC25 (infected and treated
with s-Methylcysteine, 25 mg/kg, orally); C + SMC50 (infected and treated with s-Methylcysteine, 50 mg/kg, orally).
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase.
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3.3. SMC Modulates Cryptosporidium-Induced Inflammation
To assess the mechanisms involved in the progression of cryptosporidiosis, the serum amyloid
P (SAP) and pro-inflammatory cytokines (TNF-α, IL-6, IFN-γ) were estimated (Figure 2). The data
analysis of amyloid P, TNF-α, IL-6, and IFN-γ indicated a significant elevation (p < 0.05) of their
level in Cryptosporidium-infected mice relative to the control one. The concentrations of SAP and
all pro-inflammatory cytokines were significantly lower (p < 0.05) in infected SMC-treated mice
(C + SMC50 and C + SMC25 groups, respectively) than that of untreated infected mice. The treatment
of Cryptosporidium-infected mice with a higher dose of SMC (50 mg/kg) resulted in a significant reduction
(p < 0.05) of SAP and TNF-α to their normal level when compared to the control group (Figure 2A,B).
3.4. Histopathology
Microscopically, the colonic mucosa of both control and sham groups showed normal intestinal
crypts. Intestine of C + ve showed a feature of chatarahal entritis associated with a parasitic invasion
of the epithelium of the glands, marked dequmative changes, and hyperplastic changes within the
basal aspect of the crypts. The infected animals and animals treated with SMC at both doses revealed
dose-dependent retrival of the normal intestinal mucosa as demonstrated with the decrease of parasitic
cysts, enteritis, and hyperplastic lesions (Figure 3).
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Figure 3. Intestine of different animal groups. (A) Control, (B) sham SMC50, (C) C + ve (arrowheads
indicate numerous parasitic oocysts), (D) C + SMC25, and (E) C + SMC50 both intestinal sections
showing a marked decrease of the intestinal oocyst (arrowheads). Hematoxylin and eosin (H&E) stain,
bar = 50 µm.
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The liver of control and SMC50 showed normal hepatic tissues represented mostly with normal
hepatic cells that arranged normally around the central vein. The liver of C + ve animals showed
multiple necrotic foci within the hepatic tissues associated with marked aggregation of inflammatory
cells as lymphocytes, macrophages, and esinophils give the picture of a granulomatous reaction.
Furthermore, most of the hepatocytes revealed hydropic vacuolar changes. The hepatic tissues of
infected animals treated with SMC25 demonstrated a marked decrease in the necrotic changes with
few vacuolion and mild apoptosis of the hepatoctes (Figure 4). The spleen of both the control and
sham group demonstrated normal lymphoid follicles formed of lymphoid cells aggregation around
central arteriole, while the infected mice showed a severe degree of lymphoid depletion associated
with a deposition of amyloid substances, mostly on outer the follicles (Figure 5).Biomedicines 2020, 8, x FOR PEER REVIEW 9 of 19 
 
Figure 4. Liver of different animal groups. (A) Control, (B) sham SMC50 (arrows indicate normal 
hepatocytes), (C) C + ve (arrowheads indicate granuloma-like lesion rich in a high number of 
lymphocytes, macrophages, and eosinophils), (D) C + SMC25 (arrow reveals a decrease in hepatic 
vacuolation), and (E) C + SMC50 (arrow indicates mild hepatic vacuolation). H&E stain, bar = 50 μm. 
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Interestingly, the quantitative scoring of the intestinal parasites, hepatic, and splenic lesions 
showed a marked significant decrease of the pathological lesions within the different organs in a 
dose-dependent manner (p < 0.05) (Figure 6). 
Figure 5. Spleen of different animal groups. (A) Control, (B) sham SMC50 (arrowheads indicate
normal lymphoid follicle filled with numerous lymphocytes), (C) C + ve (arrowhead indicates marked
lymphoid depletion and arrows indicate amyloid deposition), (D) C + SMC25, and (E) C + SMC50
both splenic sections showing marked improvement of lymphoid content (arrowheads). H&E stain,
bar = 50 µm.
Interestingly, the quantitative scoring of the intestinal parasites, hepatic, and splenic lesions
showed a marked significant decrease of the pathological lesions within the different organs in a
dose-dependent manner (p < 0.05) (Figure 6).
3.5. SMC Restores Intestinal Oxidative Injury Generated by Cryptosporidium
Cryptosporidium infestation impaired antioxidant complex activities, which led to a generation of
ROS. C. parvum induced oxidative stress by an elevation (p < 0.05) of malondialdehyde (MDA) content
and a reduction (p < 0.05) of SOD activities and GSH level in mice intestines as demonstrated in the
infected untreated group compared to the control group (Figure 4). On the other hand, the treatment
of mice with SMC only, C + SMC50, and C + SMC25 groups significantly corrected (p < 0.05) the levels
of MDA, GSH, as well as SOD activity toward the control level in a dose-dependent manner, when
compared to both infected and control groups (Figure 7).
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(GSH, (C)) after two weeks of s-Methylcysteine (SMC) treatment in C. parvum-infected mice. Control
(received saline, orally); SMC50 (treated with s-Methylcysteine, 50 mg/kg, orally); C + ve (infected
with 104 C. parvum oocysts); C + SMC25 (infected and treated with s-Methylcysteine, 25 mg/kg, orally);
C + SMC50 (infected and treated with s-Methylcysteine, 50 mg/kg, orally). Data were expressed as
mean ± S.D. Each bar carrying different letters (a, b, c, d) is significantly different (p < 0.05).
4. Discussion
Despite the considerable improvement in public sanitation services, enteric infections caused by protozoan
parasites remain a major risk to human and animal health as potential zoonotic pathogen. Among others,
cryptosporidiosis is an enteric infection with worldwide distribution, particularly in countries with inadequate
sewage treatment and poor water quality [11,42,43]. The lack of vaccines and effective drugs against the disease
represents a significant limiting factor in disease control [42]. Clearly, developing new drugs and vaccines that
target parasites are urgently needed.
S-Methylcysteine (SMC) is a naturally active component of many Allium plants such as onion, garlic, and
leek [21–23]. Previous studies investigated the anti-protozoal activity of garlic extracts and its phytochemicals
against several protozoal diseases including cryptosporidiosis [44]. However, our study is considered the first
to report the protective effects induced by s-Methylcysteine against the intestinal hepatic, splenic, and hepatic
damage resulting from the infection by C. parvum.
Our findings showed significant dose-dependent alleviation of stool oocyst counts with the administration
of SMC. High and low doses of SMC (C + SMC50 and C + SMC25) significantly minimized the C. parvum
oocysts count in experimentally infected mice, particularly with the higher dose (SMC, 50 mg/kg). Similar to our
results, garlic successfully extirpated the Cryptosporidium oocysts from the stool and intestinal sections of the
infected immunocompetent mice treated with garlic for two weeks [33]. The garlic oil was also proved to have
a broad-spectrum of anti-parasitic activity against certain microorganisms such as Trypanosoma, Cochlospermum
planchonii, Leishmania, Plasmodium, and Giardia [32]. The antiprotozoal effect of garlic belongs to the presence of
several phytochemicals including allicin and several organosulfur compounds as N-acetylcysteine that possess
antimicrobial activity via enhancing phagocytosis and stimulating the natural killer cells activity [45,46]. The serum
elevation of alanine aminotransferase (ALT) signalizes the cell membrane injury while aspartate aminotransferase
(AST) refers to mitochondrial damage of hepatic tissue [47]. In addition, alkaline phosphatase (ALP) is used as
an indicator of hepatobiliary disease and hepatic cellular damage [48]. In our study, an increased level of these
enzymes was demonstrated which indicated hepatocyte damages mediated by the C. parvum infection in mice.
Moreover, a marked reduction in albumin and total globulins levels was presented in C. parvum-infected mice.
Our findings corroborate with the previous results of Aboelsoued et al. [49] who recorded an elevation in
ALT and AST in experimentally infected mice with Cryptosporidium. These results emphasized the extra-intestinal
harmful effect of Cryptosporidium infection [50]. Moreover, the production of reactive oxygen species (ROS) was
clearly implicated in the pathogenesis of experimental C. parvum infection in mice and induced oxidative stress
damage in hepatic tissue [51]. The reduction in the albumin level may be attributed to hepatocellular damage, as
liver is the main organ responsible for its synthesis [52]. Additionally, it was previously reported that the level of
γ globulin was markedly reduced while albumin was insignificantly affected in Cryptosporidium infection [53]. In
this study, the serum level of liver enzymes (ALT, AST, and ALP), albumin, and globulin were restored toward the
control level referring to the suppressive effects of SMC against Cryptosporidium infestation. The high dose of
SMC (50 mg/kg) strongly ameliorated the harmful effects of C. parvum by minimizing hepatocyte damage and
decreasing serum concentrations of the above enzymes. This amelioration may be correlated to the presence of
organosulfur compounds as S-allylcystein (SAC) in garlic has various antioxidant properties via inhibiting lipid
peroxidation and has the ability to diminish the histological damage in liver of mice mediated by carcinogenic
drugs [54–56]
Serum amyloid P (SAP, pentraxin-2) is a member of C-reactive protein that regulate numerous aspects of the
innate immune system [57]. Pro-inflammatory cytokines, such as IFN-γ, IL-6, and TNF-α, are commonly secreted
by activated macrophages and are included in the inflammation up-regulation process [58]. IFN-γ triggers the
M1 macrophages expansion, ROS and NO elicitation, and apoptosis [59]. The critical roles of IFN-γ, TNF-α, and
NO in the host resistance against parasite infestation have been clarified in other studies [60,61]. Our results
exhibited an increase in pro-inflammatory cytokines secretion (TNF-α, IL-6, IFN-γ) in infected non-treated mice
compared to control ones, indicating the inflammatory responses attributed to Cryptosporidium infestation. Earlier
investigations found that α1-globulin is significantly elevated in rats infected with C. parvum [53] through an
Biomedicines 2020, 8, 423 12 of 17
increasing level of serum amyloid A and/or serum amyloid P that were previously confirmed to be increased
during infection [62] and inflammation [63]. Interestingly, a landmark study has revealed a significant increase in
the expression of TNF-α, IL-6 genes in leukocytes of C. parvum-infected mice [64]. In accordance with previous
data, the immune response during Cryptosporidium infection presented by an increasing expression of immune
mediators such as TNF-α, IL-6, IFN-γ by T-helper cell (Th1) particularly protect against intracellular infections
including C. parvum [65]. Furthermore, TNF-α together with IFN-γ helps to activate macrophages to release huge
amounts of IL-12 to control parasite replication during early Cryptosporidium infection [66].
In the present work, the treatment of infected mice with SMC decreased the release of SAP, TNF-α, IL-6,
and IFN-γ, especially with the higher dose (50 mg/kg) that could return SAP and TNF-α to their normal level.
SMC employs its anti-inflammatory activities through suppressing the expression of NF-kB p65 and NF-kB
p50, restricted p38 phosphorylation, and reduced inflammatory mediators. Moreover, SMC effectively inhibited
cyclooxygenase-2 (COX-2)/prostaglandin E(2) (PGE(2) pathways which are considered potent mediators in several
inflammatory diseases [67]. Another mechanism is that aged black garlic (ABG) extract could act by prohibiting
the inducible nitric oxide synthase (iNOS) and COX-2 expression, and, consequently, prevented IL-6 and TNF-α
formation [68]. Additionally, the oral administration of SMC could significantly decrease the plasma level of
TNF-α in diabetic rats [29].
Regarding the histopathological findings, several previous studies documented various pathological lesions
induced by the infection by Cryptosporidium spp. in immunocompromised and immunocompetent hosts [69–72]. In
this concern, a high-grade of cell dysplasia in the liver and ileum with the evidence of dysplastic changes in the bile
has been demonstrated previously by Certad et al. [73] and Abdou et al. [74]. The hepatotoxicity was previously
confirmed in our results by elevation of serum liver enzymes. Microscopic examination of Cryptosporidium-infected
ileum showed atrophy, degeneration, and necrosis with sloughing of villi upper tips. Thickening and flat villi with
inflammatory cellular infiltration in submucosa and lamina propria were also detected [53]. The amelioration of
the intestinal inflammation mediated by garlic aqueous extract has been suggested by Gaafar [33] who found a
decrease in myeloperoxidase (MPO) activity, a reliable index of inflammation intensity, which is coincided with
altered mucosal architecture, blunting, widening, and shortening of the intestinal villi in case of cryptosporidiosis.
Restoring the histopathological alterations in liver, spleen, and intestine architectures in response to the SMC
treatment were reliable even in terms of biochemical and inflammatory markers. The strategy of SMC to restore
tissue architecture may be correlated to the ability of garlic organosulfur compounds as S-allylcystein (SAC) to
reduce lipid peroxidation and oxidative stress damage through scavenging O2-, H2O2, and HO. They also have
anti-inflammatory effects through inhibition of iNOS expression in macrophages to regulate NO production [75,76].
Incrimination of ROS production has been reported in many pathological diseases infecting the gastrointestinal
tract like inflammatory bowel disease [77]. The known function of SOD is catalyzing the toxic superoxide radical
into less toxic hydrogen peroxide [78]. The highly considerable thiol antioxidant is GSH that present in the blood
and different tissues and showed a major role in the detoxification of varied toxic compounds like xenobiotics and
carcinogens and subsequently preserved the protein structure of the cell [79]. In the current study, C. parvum
generated oxidative stress by elevation of MDA content and reducing SOD activity and the GSH level in the
infected mice. A significant decline in the values of glutathione peroxidase (GPX) and total antioxidant capacity
was also reported in C. parvum-infected mice [49]. The oxidative injury following C. parvum infestation was
previously reported by other researchers who exhibited a decrease in GSH level and SOD activity [51,80,81].
This data emphasizes the oxidative stress linked to Cryptosporidium infection, suggesting that dealing with infection
creates an overload on the animal that could exaggerate the oxidative injury [82].
Treatment with SMC modified the Cryptosporidium-generated oxidative damage by improving antioxidant
content (SOD and GSH) and reducing the MDA level in intestinal tissue. GSH- and GSH-dependent enzyme,
GPx, could be restored after SMC treatment in diabetic rats explaining the antioxidant property of SMC and its
ability to conserve the cell components from free radical injuries [29]. Furthermore, The potential antioxidant
effect of garlic extract was clarified in a previous report, that demonstrated an increase of SOD activity and other
antioxidants due to the presence of different flavonoids and sulfur compounds as SMC in garlic that have high
radical scavenging activities [44]. This effect may be correlated to the ability of SMC to inhibit NADPH oxidase
pathway through down-regulation of p47phox and gp91phox expressions, which are components of the NADPH
oxidase enzyme, subsequently depressing ROS production [67]. Surprisingly, Abdel-Daim et al. [83] revealed
that Diallyl sulfide, one of the garlic sulfur compounds, exerts its antioxidant property by stimulating the mRNA
expression of Nrf2 and the heme-oxygenase 1 enzyme.
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5. Conclusions
Our study investigated the impacts of cryptosporidiosis on the intestine, spleen, and liver of mice.
Additionally, the study corroborated the role of SMC (at doses of 25 and 50 mg/kg b.w.) in attenuating
C. parvum-induced hepatic, splenic, and intestinal damage consequences, via enhancing the ability of antioxidant
enzymes and suppressing the release of inflammatory mediators.
Indeed, our results emphasize the importance of SMC co-administration as an effective and safe therapy for
treating and declining C. parvum infestation. However, more investigation should be applied before approving
SMC either alone or in association with other available drugs for the treatment of cryptosporidiosis. Our study
also suggests that further future research seems mandatory to explore more mechanistic actions and pathways
underlying the effects of SMC in cryptosporidiosis and the role of remaining reactive oxygen and nitrogen species
in various organs, which is important for combating this disease of zoonotic importance.
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